Financial Snapshot

Revenue
$96.19M
TTM
Gross Margin
85.89%
TTM
Net Earnings
-$72.71M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
48.22%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
-$97.28M
Q4 2024
Cash
Q4 2024
P/E
-0.9815
Nov 29, 2024 EST
Free Cash Flow
-$44.40M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue $128.9M $8.573M $63.57M $20.34M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 1404.02% -86.51% 212.55%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue $128.9M $8.573M $63.57M $20.34M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $8.886M
Gross Profit -$313.0K
Gross Profit Margin -3.65%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

No data

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

No data

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Selling, General & Admin $49.80M $68.13M $78.80M $64.40M $79.58M $69.65M $40.33M $24.73M $16.83M $12.71M $3.760M $830.0K
YoY Change -26.91% -13.54% 22.36% -19.08% 14.26% 72.7% 63.08% 46.94% 32.42% 238.03% 353.01%
% of Gross Profit
Research & Development $151.5M $219.2M $270.0M $282.0M $244.7M $216.1M $167.5M $81.21M $56.51M $41.62M $15.45M $4.306M $3.260M
YoY Change -30.88% -18.82% -4.26% 15.27% 13.21% 29.05% 106.21% 43.69% 35.79% 169.44% 258.71% 32.09%
% of Gross Profit
Depreciation & Amortization $2.700M $4.829M $5.653M $9.345M $8.330M $7.070M $3.730M $960.0K $383.0K $48.00K $6.000K $4.000K $0.00
YoY Change -44.09% -14.58% -39.51% 12.18% 17.82% 89.54% 288.54% 150.65% 697.92% 700.0% 50.0%
% of Gross Profit
Operating Expenses $151.5M $269.0M $338.1M $360.8M $309.1M $295.7M $237.1M $121.5M $56.51M $58.45M $28.16M $8.615M $4.090M
YoY Change -43.68% -20.45% -6.29% 16.74% 4.52% 24.7% 95.1% 115.05% -3.31% 107.59% 226.83% 110.64%
Operating Profit -$83.44M -$269.3M -$280.5M -$340.5M -$309.1M -$295.7M -$237.1M -$121.5M -$58.45M -$28.16M -$8.615M
YoY Change -69.01% -4.01% -17.61% 10.16% 4.52% 24.7% 95.1% 107.59% 226.83%

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Interest Expense $4.615M $141.0K $1.986M $367.0K $2.450M $4.720M $6.370M $2.030M $2.200M $1.220M $130.0K $10.00K $0.00
YoY Change 3173.05% -92.9% 441.14% -85.02% -48.09% -25.9% 213.79% -7.73% 80.33% 838.46% 1200.0%
% of Operating Profit
Other Income/Expense, Net $528.0K -$246.0K -$700.0K $2.447M $4.717M $6.368M $2.027M $2.203M $1.218M $125.0K $12.00K
YoY Change -314.63% -64.86% -48.12% -25.93% 214.16% -7.99% 80.87% 874.4% 941.67%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Pretax Income -$85.42M -$276.1M -$228.3M -$340.1M -$306.6M -$291.0M -$230.7M -$119.5M -$48.80M -$57.23M -$28.03M -$8.603M -$4.090M
YoY Change -69.06% 20.95% -32.87% 10.92% 5.38% 26.1% 93.08% 144.91% -14.74% 104.17% 225.83% 110.34%
Income Tax -$12.00K $15.00K $12.00K $46.00K $15.00K $12.00K -$44.00K -$14.00K $10.00K -$9.000K -$25.00K $170.0K $20.00K
% Of Pretax Income
Net Earnings -$85.40M -$276.1M -$228.3M -$340.1M -$306.6M -$291.0M -$230.7M -$119.5M -$79.05M -$57.22M -$28.01M -$8.773M -$4.110M
YoY Change -69.07% 20.95% -32.88% 10.93% 5.38% 26.13% 93.07% 51.16% 38.15% 104.32% 219.23% 113.45%
Net Earnings / Revenue -66.23% -3220.88% -359.12% -1672.28%
Basic Earnings Per Share -$11.41 -$2.61 -$2.24
Diluted Earnings Per Share -$11.41 -$2.61 -$2.24 -$3.631M -$4.145M -$5.671M -$5.266M -$4.002M -$2.751M -$2.237M -$5.613M -$452.1K -$211.9K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Cash & Short-Term Investments $51.73M $242.8M $371.1M $500.7M $259.1M $309.6M $166.1M $255.7M $320.5M $104.1M $51.60M $4.200M
YoY Change -78.7% -34.56% -25.89% 93.25% -16.31% 86.39% -35.04% -20.22% 207.88% 101.74% 1128.57%
Cash & Equivalents $25.84M $92.94M $106.1M $200.4M $74.30M $60.70M $79.20M $48.00M $23.70M $21.90M $51.60M $4.200M
Short-Term Investments $25.88M $149.9M $265.0M $300.3M $184.8M $248.9M $86.90M $207.7M $296.7M $82.20M $0.00 $0.00
Other Short-Term Assets $6.330M $10.45M $12.57M $21.40M $13.90M $11.90M $6.100M $4.900M $4.100M $1.900M $200.0K $0.00
YoY Change -39.45% -16.81% -41.28% 53.96% 16.81% 95.08% 24.49% 19.51% 115.79% 850.0%
Inventory $9.706M $1.586M
Prepaid Expenses
Receivables $34.11M $40.22M $986.0K $1.300M
Other Receivables $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $101.9M $295.1M $384.6M $523.3M $273.0M $321.5M $172.2M $260.6M $324.6M $106.0M $51.80M $4.200M
YoY Change -65.48% -23.28% -26.5% 91.68% -15.09% 86.7% -33.92% -19.72% 206.23% 104.63% 1133.33%
Property, Plant & Equipment $58.79M $74.32M $79.94M $62.80M $68.20M $68.60M $44.10M $3.300M $300.0K $0.00 $0.00 $0.00
YoY Change -20.9% -7.03% 27.29% -7.92% -0.58% 55.56% 1236.36% 1000.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.844M $7.018M $3.567M $2.000M $1.800M $1.800M $1.500M $100.0K $100.0K $0.00 $0.00 $0.00
YoY Change -30.98% 96.75% 78.35% 11.11% 0.0% 20.0% 1400.0% 0.0%
Total Long-Term Assets $63.64M $81.34M $83.51M $64.80M $69.90M $70.30M $45.60M $3.300M $400.0K $100.0K $0.00 $100.0K
YoY Change -21.77% -2.59% 28.87% -7.3% -0.57% 54.17% 1281.82% 725.0% 300.0% -100.0%
Total Assets $165.5M $376.4M $468.1M $588.1M $342.9M $391.8M $217.8M $263.9M $325.0M $106.1M $51.80M $4.300M
YoY Change
Accounts Payable $3.684M $6.871M $17.37M $7.100M $8.000M $3.700M $14.70M $2.800M $1.400M $400.0K $600.0K $100.0K
YoY Change -46.38% -60.44% 144.62% -11.25% 116.22% -74.83% 425.0% 100.0% 250.0% -33.33% 500.0%
Accrued Expenses $59.79M $63.21M $47.49M $42.10M $28.50M $29.80M $9.700M $6.200M $7.700M $1.200M $300.0K $100.0K
YoY Change -5.41% 33.11% 12.8% 47.72% -4.36% 207.22% 56.45% -19.48% 541.67% 300.0% 200.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $915.0K $834.0K $171.0K $300.0K $300.0K
YoY Change 9.71% 387.72% -43.0% 0.0%
Total Short-Term Liabilities $142.2M $78.92M $105.8M $82.90M $36.70M $40.00M $27.60M $9.700M $9.700M $2.700M $1.500M $1.300M
YoY Change 80.22% -25.4% 27.61% 125.89% -8.25% 44.93% 184.54% 0.0% 259.26% 80.0% 15.38%
Long-Term Debt $34.65M $3.643M $0.00 $100.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 851.19% -100.0% -50.0%
Other Long-Term Liabilities $87.86M $167.2M $82.73M $42.70M $15.20M $13.00M $12.30M $500.0K $200.0K $200.0K $200.0K $0.00
YoY Change -47.46% 102.14% 93.74% 180.92% 16.92% 5.69% 2360.0% 150.0% 0.0% 0.0%
Total Long-Term Liabilities $122.5M $170.9M $82.73M $42.80M $15.40M $13.00M $12.30M $500.0K $200.0K $200.0K $200.0K $0.00
YoY Change -28.3% 106.54% 93.29% 177.92% 18.46% 5.69% 2360.0% 150.0% 0.0% 0.0%
Total Liabilities $264.7M $249.8M $188.5M $125.8M $52.20M $53.00M $39.90M $10.20M $9.900M $2.900M $1.800M $1.300M
YoY Change 5.99% 32.5% 49.85% 141.0% -1.51% 32.83% 291.18% 3.03% 241.38% 61.11% 38.46%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Basic Shares Outstanding 7.488M 105.9M 102.0M
Diluted Shares Outstanding 7.488M 105.9M 102.0M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $71.363 Million

About Atara Biotherapeutics, Inc.

Atara Biotherapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Thousand Oaks, California and currently employs 159 full-time employees. The company went IPO on 2014-10-16. Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The firm is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. Its pipeline products include Ebvallo (Tab-cel), ATA3219. The Company’s T-cell immunotherapy, tab-cel (tabelecleucel), is in Phase III development for patients with EBV-driven post-transplant lymphoproliferative disease (EBV+ PTLD) who have failed rituximab or rituximab plus chemotherapy, as well as other EBV-driven diseases. Its ATA3219 is in Phase 1 development is being developed as a potential product intended to target B-cell malignancies and autoimmune diseases, based on a next generation 1XX co-stimulatory domain and the innate advantages of EBV T cells as the foundation for an allogeneic CAR T platform.

Industry: Biological Products, (No Diagnostic Substances) Peers: BioXcel Therapeutics, Inc. KalVista Pharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc. Foghorn Therapeutics Inc. Karyopharm Therapeutics Inc. Prelude Therapeutics Inc Scholar Rock Holding Corp Vigil Neuroscience, Inc. Tyra Biosciences, Inc.